Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1995
10/24/1995CA1337446C Pan emulsion
10/24/1995CA1337399C Ibuprofen taste-masking process
10/24/1995CA1337398C Pharmaceuticals microencapsulated by vapor deposited polymers and method
10/24/1995CA1337397C Emulsified composition
10/24/1995CA1337396C Compositions and in situ methods for forming films on body tissue
10/23/1995CA2147020A1 Processing aid and product enhancer
10/19/1995WO1995027699A1 Aminostilbazole derivative and medicine
10/19/1995WO1995027508A1 Composition for use in raising an immune response
10/19/1995WO1995027506A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027492A1 Halofantrine free base for the treatment of malaria and compositions
10/19/1995WO1995027488A1 Solid vitamin c preparation and a method of producing the same
10/19/1995WO1995027483A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
10/19/1995WO1995027482A1 Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
10/19/1995WO1995027481A1 Liquid delivery compositions
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995027479A1 Multilamellar drug delivery systems
10/19/1995WO1995027478A1 Fusogenic liposomes and methods of making and using same
10/19/1995WO1995027477A1 Gelified microspheres, method of preparation and applications
10/19/1995WO1995027476A1 Hydrofluorocarbon propellant containing medicinal aerosols
10/19/1995WO1995027475A1 Process and apparatus for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
10/19/1995DE4413350A1 Retard-Matrixpellets und Verfahren zu ihrer Herstellung Slow-release matrix pellets, and methods for their preparation
10/19/1995DE4411425A1 Prepn. of tumour vaccine for active specific immuno-therapy
10/19/1995CA2187551A1 Gelified microspheres, method of preparation and applications
10/19/1995CA2187367A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995CA2187185A1 Halofantrine free base for the treatment of malaria and compositions
10/19/1995CA2164729A1 Catalase-based anti-helicobacter pylori immunising composition
10/18/1995EP0677332A2 Methods and apparatus for fine particle formation
10/18/1995EP0677322A2 Method for preparing aqueous emulsion for coating solid pharmaceutical preparations
10/18/1995EP0677295A1 Liposome having oligosaccharide on the surface
10/18/1995EP0677290A1 Percutaneous preparation comprising tulobuterol
10/18/1995EP0677126A1 Antiviral topical pharmaceutical compositions
10/18/1995EP0677103A1 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
10/18/1995EP0676967A1 Readily available konjac glucomannan sustained release excipient
10/18/1995EP0676962A1 Enhanced pharmaceutical compositions for skin penetration
10/18/1995EP0676957A1 Oral care composition coated gum
10/18/1995EP0676956A1 A method for preparing pharmaceutical compositions through ultrasonic means
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0676953A1 Plasticized bioerodible controlled delivery system
10/18/1995EP0676952A1 Bioerodible controlled delivery system
10/18/1995EP0676950A1 Oral compositions
10/18/1995EP0676945A1 Encapsulation apparatus and process
10/18/1995EP0676935A1 Angiogenic tissue implant systems and methods
10/18/1995EP0596935B1 Antiviral pharmaceutical compositions for vaginal administration
10/18/1995EP0569393B1 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition
10/18/1995EP0533799B1 Compositions and methods for the controlled release of soluble active substances
10/18/1995EP0494297B1 Galenical preparation method for preparing a therapeutical composition particularly based on aspirin
10/18/1995EP0490916B1 Compositions and methods of manufacture of oral dissolvable medicaments
10/18/1995CN2209984Y Medicinal towel for haemorrhoids
10/18/1995CN2209983Y Medicinal prepn. easily for suction
10/18/1995CN1110178A Superoxide dismutase capsule and preparation method thereof
10/18/1995CN1110173A Jiuxin Yidiling liquid medicine for curing heart disease
10/18/1995CN1110170A Shangfuling spray-filming agent for curing wound and skin disease
10/18/1995CN1110169A Red sage root injection
10/18/1995CN1110158A Zizhi medical cream
10/18/1995CN1110154A Sugar-free sarcandra glabra lozenge
10/18/1995CN1110149A Compound tsaoko injection and preparation method thereof
10/18/1995CN1110141A Compound Yantongtuoshuang cream
10/18/1995CN1110137A Trace element medicinal film for human body
10/18/1995CN1110136A Enteric solubility bacterial enzyme composite bed microcapsule preparation and its preparing method
10/18/1995CN1110135A Pharmaceutical composition for controlled release
10/18/1995CN1110134A Liposome preparing technology and preparation thereof
10/18/1995CN1110133A Bolbostemma paniculatum glucoside A suppository
10/18/1995CN1110090A Chewing gum relieving sore-throat and preparation method thereof
10/17/1995US5459263 Convert trichlorotrazine to diaminochlorotriazine,then to melarsen acid hydrochloride, reduce to melarsenoxide, react with cysteamine hydrochloride
10/17/1995US5459165 Fluorine-containing, polyglycerolated amphiphilic sulphur compounds, cosmetic or pharmaceutical composition containing them, preparation process and vesicles formed
10/17/1995US5459157 Pharmaceutical composition for ophthalmic use comprising a nonsteroidal anti-inflammatory and a decongestant drug
10/17/1995US5459127 Cationic lipids for intracellular delivery of biologically active molecules
10/17/1995US5459054 Cells encapsulated in alginate containing a high content of a- l- guluronic acid
10/17/1995US5458890 Methods and compositions for flavoring orally-delivered products
10/17/1995US5458888 Controlled release tablet formulation
10/17/1995US5458887 Of an osmotic core containing a drug and a water swellable component and a water resistant polymer coating containing a compound which dissolves in gastrointestinal fluid
10/17/1995US5458886 Free-flowing granular antacid compositions containing titanium dioxide and polysiloxane
10/17/1995US5458885 Transdermal drug delivery device
10/17/1995US5458884 Bioerodible device for administering active ingredients
10/17/1995US5458883 Method of treating disorders of the eye
10/17/1995US5458879 Oral vehicle compositions
10/17/1995US5458873 Carboxyvinyl polymer having Newtonian viscosity
10/17/1995US5457895 Method of identifying freeze-dried dosage forms
10/17/1995CA2001671C Aqueous elcatonin solution composition
10/17/1995CA1337332C Influenza vaccine and novel adjuvants
10/17/1995CA1337331C Intranasal vaccination of horses with inactivated micro-organisms or antigenic material
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995027043A1 Antibacterial therapy with genotypically modified bacteriophage
10/12/1995WO1995026778A1 A topical dressing, method of manufacturing a topical dressing and use of a topical dressing
10/12/1995WO1995026768A1 Methods for treating pulmonary vasoconstriction and asthma
10/12/1995WO1995026753A1 Process for producing sustained-release tablets and enteric tablets
10/12/1995WO1995026750A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
10/12/1995WO1995026748A1 Use of mcp-1 for inducing ripening of the cervix
10/12/1995WO1995026739A2 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions
10/12/1995WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995WO1995026715A2 Use of fatty acid esters as bioadhesive substances
10/12/1995WO1995026714A1 Living cells microencapsulated in a polymeric membrane
10/12/1995WO1995026713A1 Heterofunctional, mucoadhesive dosage form
10/12/1995WO1995026712A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995WO1995026711A1 Ophthalmic composition with decreased viscosity
10/12/1995WO1995026707A1 Dialkyl ether-containing micro-emulsions
1 ... 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 ... 2991